5-Bromopyrimidine → 6-Cyclopropyl-3-(pyrimidin-5-ylamino)-pyridine-2-carboxylic acid (1-methyl-1H-pyrazol-3-yl)-amide
Reaction equation
[CH3:1][N:2]1[CH:6]=[CH:5][C:4]([NH:7][C:8]([C:10]2[C:15]([NH2:16])=[CH:14][CH:13]=[C:12]([CH:17]3[CH2:19][CH2:18]3)[N:11]=2)=[O:9])=[N:3]1.Br[C:21]1[CH:22]=[N:23][CH:24]=[N:25][CH:26]=1>>[CH3:1][N:2]1[CH:6]=[CH:5][C:4]([NH:7][C:8]([C:10]2[C:15]([NH:16][C:21]3[CH:22]=[N:23][CH:24]=[N:25][CH:26]=3)=[CH:14][CH:13]=[C:12]([CH:17]3[CH2:19][CH2:18]3)[N:11]=2)=[O:9])=[N:3]1Participants
3
Procedure
The title compound, was prepared from 3-Amino-6-cyclopropyl-pyridine-2-carboxylic acid (1-methyl-1H-pyrazol-3-yl)-amide and 5-bromopyrimidine in accordance with the general method of example 4 using to yield the final compound as a yellow crystalline solid, MS (ISP): m/e=336.1 (M+H+).
Sources & evidence
- ORD record
- ord-3ef88952e9ab4672beff5c072cf42740
- Source dataset
- uspto-grants-2008_08
- Patent number
- US07414060B2
Reaction notes
Loading…